Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fors

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
American Journal of Mental Retardation : AJMR|January 1, 1990
Maternal directive behavior revisitedG Mahoney, S Fors, S Wood
International Journal of Pharmaceutics|October 16, 1999
Apparatus for studying in vitro drug release from medicated chewing gumsC Kvist, S B Andersson, S Fors, et al.
The Journal of Organic Chemistry|October 24, 2001
A Convergent, Scalable Synthesis of HIV Protease Inhibitor PNU-140690Kristina S. Fors, James R. Gage, Richard F. Heier, et al.
Journal of Medicinal Chemistry|October 3, 2012
Application of structure-based drug design and parallel chemistry to identify selective, brain penetrant, in vivo active phosphodiesterase 9A inhibitorsMichelle M Claffey, Christopher J Helal, Patrick R Verhoest, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
American Journal of Mental Retardation : AJMR|January 1, 1990
Maternal directive behavior revisitedG Mahoney, S Fors, S Wood
International Journal of Pharmaceutics|October 16, 1999
Apparatus for studying in vitro drug release from medicated chewing gumsC Kvist, S B Andersson, S Fors, et al.
The Journal of Organic Chemistry|October 24, 2001
A Convergent, Scalable Synthesis of HIV Protease Inhibitor PNU-140690Kristina S. Fors, James R. Gage, Richard F. Heier, et al.
Journal of Medicinal Chemistry|October 3, 2012
Application of structure-based drug design and parallel chemistry to identify selective, brain penetrant, in vivo active phosphodiesterase 9A inhibitorsMichelle M Claffey, Christopher J Helal, Patrick R Verhoest, et al.
Pageof 1